Needham & Company
-
LifeLock to Present at the Needham Growth Conference
-
Notable Analyst Rating Changes 12/18: (CRM) (COLM) (DERM) Upgraded; (FOSL) (LHO) (SDLP) Downgraded
-
Needham & Company Reinstates LifeLock (LOCK) at Buy
-
LifeLock Names Sharon Segev as General Counsel
-
LifeLock (LOCK) Rating Suspended at Needham & Company Following FTC Lawsuit
-
LifeLock (LOCK) Q1 'Solid', Needham & Company Says; PT Trimmed to $21
-
LifeLock (LOCK) Q4 Results OK But Constructive Dialogue with FTC the Big News - Needham & Company
-
Needham & Company Reiterated Bullish Stance on LifeLock (LOCK) Despite Wallet Disclosure
-
LifeLock (LOCK) Bullish View Reiterated at Needham & Company
-
Needham & Company Maintains Bullish Stance on LifeLock (LOCK) Post Analyst Day
-
LifeLock (LOCK) Target Lifted to $26 at Needham & Company
-
After Serious Outperformace in 2013, Needham & Company Lays Out 2014's Top Stock Picks
-
Needham & Company Lifts PT on LifeLock (LIFE) to $18
-
Analysts Call LifeLock's (LOCK) First Report Since IPO a Success
-
Needham & Company Starts LifeLock (LOCK) at Buy
-
LifeLock (LOCK) IPO Opens Lower
-
LifeLock (LOCK) Prices IPO at $9/Share, Below Expectations
-
Personal ID Security Provider LifeLock (LOCK) Files $175M IPO